US Global Investors Funds’s Regeneron Pharmaceuticals REGN Stock Holding History

US Global Investors Funds’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$248K	Buy	+900	New	+$259K	0.04%	223

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

US Global Investors Funds's REGN Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2013: 900 shares worth $248K. The stake represents 0.04% of the portfolio and ranks #223 among its holdings.

438 funds tracked by Wall St. Rank hold REGN as of Q4 2013.

US Global Investors Funds held 900 shares of Regeneron Pharmaceuticals worth $248K as of Q4 2013.
Regeneron Pharmaceuticals was a new US Global Investors Funds position in Q4 2013.
Regeneron Pharmaceuticals made up 0.04% of US Global Investors Funds's portfolio in Q4 2013, its #223 holding.
438 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.